Oliver Van Hecke
Oxford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
Amitriptyline for the prevention of post herpetic neuralgia: study protocol for the ATHENA study.
Journal: Skin health and disease
Published: March 24, 2025
Re: Impact of C-reactive protein point-of-care testing on antibiotic prescriptions for children and adults with suspected respiratory tract infections in primary care by Jung et al.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: September 11, 2024
Health outcomes 3 months and 6 months after molnupiravir treatment for COVID-19 for people at higher risk in the community (PANORAMIC): a randomised controlled trial.
Journal: The Lancet. Infectious diseases
Published: May 02, 2024
C-reactive protein point-of-care testing in primary care-broader implementation needed to combat antimicrobial resistance.
Journal: Frontiers in public health
Published: March 11, 2024
Impact of pharmacist-prescriber partnerships to track antibiotic prescribing in publicly funded primary care in the Cape Town metropole, South Africa: An implementation study.
Journal: South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde
Published: February 05, 2024
'Everyone has heard of it, but no one knows what it is': a qualitative study of patient understandings and experiences of herpes zoster.
Journal: The British journal of general practice : the journal of the Royal College of General Practitioners
Published: January 12, 2024
Cost-utility analysis of molnupiravir for high-risk, community-based adults with COVID-19: an economic evaluation of the PANORAMIC trial.
Journal: The British journal of general practice : the journal of the Royal College of General Practitioners
Published: August 25, 2023
Platform adaptive trial of novel antivirals for early treatment of COVID-19 In the community (PANORAMIC): protocol for a randomised, controlled, open-label, adaptive platform trial of community novel antiviral treatment of COVID-19 in people at increased risk of more severe disease.
Journal: BMJ open
Published: August 07, 2023
Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients.
Journal: Nature communications
Published: August 04, 2023
C-reactive protein point-of-care testing and complementary strategies to improve antibiotic stewardship in children with acute respiratory infections in primary care.
Journal: Frontiers in pediatrics
Published: May 22, 2023
Inhaled Budesonide for COVID-19 in People at Higher Risk of Complications in the Community: The UK National Community Randomi.
Journal: Annals of family medicine
Published: March 21, 2023
Last Updated: 09/26/2026